Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 1
2008 2
2009 1
2010 3
2011 1
2012 3
2013 5
2014 6
2015 7
2016 4
2017 4
2018 14
2019 5
2020 2
2021 8
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

58 results
Results by year
Filters applied: . Clear all
Page 1
MYCN-Amplified Neuroblastoma Is Addicted to Iron and Vulnerable to Inhibition of the System Xc-/Glutathione Axis.
Floros KV, Cai J, Jacob S, Kurupi R, Fairchild CK, Shende M, Coon CM, Powell KM, Belvin BR, Hu B, Puchalapalli M, Ramamoorthy S, Swift K, Lewis JP, Dozmorov MG, Glod J, Koblinski JE, Boikos SA, Faber AC. Floros KV, et al. Among authors: faber ac. Cancer Res. 2021 Apr 1;81(7):1896-1908. doi: 10.1158/0008-5472.CAN-20-1641. Epub 2021 Jan 22. Cancer Res. 2021. PMID: 33483374
Paragangliomas in Carney-Stratakis Syndrome.
Khurana A, Mei L, Faber AC, Smith SC, Boikos SA. Khurana A, et al. Among authors: faber ac. Horm Metab Res. 2019 Jul;51(7):437-442. doi: 10.1055/a-0918-8340. Epub 2019 Jun 7. Horm Metab Res. 2019. PMID: 31174229 Review.
Patient-derived models of acquired resistance can identify effective drug combinations for cancer.
Crystal AS, Shaw AT, Sequist LV, Friboulet L, Niederst MJ, Lockerman EL, Frias RL, Gainor JF, Amzallag A, Greninger P, Lee D, Kalsy A, Gomez-Caraballo M, Elamine L, Howe E, Hur W, Lifshits E, Robinson HE, Katayama R, Faber AC, Awad MM, Ramaswamy S, Mino-Kenudson M, Iafrate AJ, Benes CH, Engelman JA. Crystal AS, et al. Among authors: faber ac. Science. 2014 Dec 19;346(6216):1480-6. doi: 10.1126/science.1254721. Epub 2014 Nov 13. Science. 2014. PMID: 25394791 Free PMC article.
Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition.
Hata AN, Niederst MJ, Archibald HL, Gomez-Caraballo M, Siddiqui FM, Mulvey HE, Maruvka YE, Ji F, Bhang HE, Krishnamurthy Radhakrishna V, Siravegna G, Hu H, Raoof S, Lockerman E, Kalsy A, Lee D, Keating CL, Ruddy DA, Damon LJ, Crystal AS, Costa C, Piotrowska Z, Bardelli A, Iafrate AJ, Sadreyev RI, Stegmeier F, Getz G, Sequist LV, Faber AC, Engelman JA. Hata AN, et al. Among authors: faber ac. Nat Med. 2016 Mar;22(3):262-9. doi: 10.1038/nm.4040. Epub 2016 Feb 1. Nat Med. 2016. PMID: 26828195 Free PMC article.
Classification of gastrointestinal stromal tumor syndromes.
Gopie P, Mei L, Faber AC, Grossman SR, Smith SC, Boikos SA. Gopie P, et al. Among authors: faber ac. Endocr Relat Cancer. 2018 Feb;25(2):R49-R58. doi: 10.1530/ERC-17-0329. Epub 2017 Nov 23. Endocr Relat Cancer. 2018. PMID: 29170162 Review.
OVOL2 in metastasis prevention in NPC.
Song KA, Faber AC. Song KA, et al. Among authors: faber ac. Theranostics. 2018 Mar 8;8(8):2242-2244. doi: 10.7150/thno.25181. eCollection 2018. Theranostics. 2018. PMID: 29721076 Free PMC article.
Gastrointestinal Stromal Tumors: The GIST of Precision Medicine.
Mei L, Smith SC, Faber AC, Trent J, Grossman SR, Stratakis CA, Boikos SA. Mei L, et al. Among authors: faber ac. Trends Cancer. 2018 Jan;4(1):74-91. doi: 10.1016/j.trecan.2017.11.006. Epub 2017 Dec 23. Trends Cancer. 2018. PMID: 29413424 Review.
58 results